Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Borg

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Acta Oncologica (Stockholm, Sweden)|October 1, 2019
Palliative short-course hypofractionated radiotherapy followed by chemotherapy in esophageal adenocarcinoma: the phase II PALAESTRA trialDavid Borg, Jan Sundberg, Eva Brun, et al.
Disability and Rehabilitation|July 16, 2021
The impact of obstacles to health and rehabilitation services on functioning and disability: a prospective survey on the 12-months after discharge from specialist rehabilitation for acquired brain injuryMelissa Legg, Michele Foster, Rachel Jones, et al.
Frontiers in Oncology|April 2, 2019
Expression of PD-L1 and PD-1 in Chemoradiotherapy-Naïve Esophageal and Gastric Adenocarcinoma: Relationship With Mismatch Repair Status and SurvivalMaria C Svensson, David Borg, Cheng Zhang, et al.
Future Oncology (London, England)|June 2, 2016
Pancreatic cancer: yesterday, today and tomorrowDaniel Ansari, Bobby Tingstedt, Bodil Andersson, et al.
International Journal of Sports Physiology and Performance|May 12, 2025
Head, Face, and Neck Cooling for Performance: A Systematic Review and Meta-AnalysisChristopher J Stevens, David Borg, Carly Brade, et al.
Oncotarget|October 27, 2017
The integrative clinical impact of tumor-infiltrating T lymphocytes and NK cells in relation to B lymphocyte and plasma cell density in esophageal and gastric adenocarcinomaMaria C Svensson, Carl Fredrik Warfvinge, Richard Fristedt, et al.
Cancer Immunology, Immunotherapy : CII|April 2, 2024
The prognostic and potentially immunomodulatory role of cartilage oligomeric matrix protein in patients with gastric and esophageal adenocarcinomaKonstantinos S Papadakos, Gilar Gorji-Bahri, Chrysostomi Gialeli, et al.
Cancers|April 3, 2021
Development of a Novel Weighted Ranking Method for Immunohistochemical Quantification of a Heterogeneously Expressed Protein in Gastro-Esophageal CancersCathy E Richards, Katherine M Sheehan, Elaine W Kay, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|May 14, 2026
Health-related quality of life comparing standard and prolonged time-to-surgery after neoadjuvant chemoradiotherapy for esophageal cancer: results from the multicenter, randomized, controlled NeoRes II trialAnders Holmén, Fahad Murad, Klara Nilsson, et al.
Ebiomedicine|February 1, 2023
An immune score reflecting pro- and anti-tumoural balance of tumour microenvironment has major prognostic impact and predicts immunotherapy response in solid cancersArtur Mezheyeuski, Max Backman, Johanna Mattsson, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Acta Oncologica (Stockholm, Sweden)|October 1, 2019
Palliative short-course hypofractionated radiotherapy followed by chemotherapy in esophageal adenocarcinoma: the phase II PALAESTRA trialDavid Borg, Jan Sundberg, Eva Brun, et al.
Disability and Rehabilitation|July 16, 2021
The impact of obstacles to health and rehabilitation services on functioning and disability: a prospective survey on the 12-months after discharge from specialist rehabilitation for acquired brain injuryMelissa Legg, Michele Foster, Rachel Jones, et al.
Frontiers in Oncology|April 2, 2019
Expression of PD-L1 and PD-1 in Chemoradiotherapy-Naïve Esophageal and Gastric Adenocarcinoma: Relationship With Mismatch Repair Status and SurvivalMaria C Svensson, David Borg, Cheng Zhang, et al.
Future Oncology (London, England)|June 2, 2016
Pancreatic cancer: yesterday, today and tomorrowDaniel Ansari, Bobby Tingstedt, Bodil Andersson, et al.
International Journal of Sports Physiology and Performance|May 12, 2025
Head, Face, and Neck Cooling for Performance: A Systematic Review and Meta-AnalysisChristopher J Stevens, David Borg, Carly Brade, et al.
Oncotarget|October 27, 2017
The integrative clinical impact of tumor-infiltrating T lymphocytes and NK cells in relation to B lymphocyte and plasma cell density in esophageal and gastric adenocarcinomaMaria C Svensson, Carl Fredrik Warfvinge, Richard Fristedt, et al.
Cancer Immunology, Immunotherapy : CII|April 2, 2024
The prognostic and potentially immunomodulatory role of cartilage oligomeric matrix protein in patients with gastric and esophageal adenocarcinomaKonstantinos S Papadakos, Gilar Gorji-Bahri, Chrysostomi Gialeli, et al.
Cancers|April 3, 2021
Development of a Novel Weighted Ranking Method for Immunohistochemical Quantification of a Heterogeneously Expressed Protein in Gastro-Esophageal CancersCathy E Richards, Katherine M Sheehan, Elaine W Kay, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|May 14, 2026
Health-related quality of life comparing standard and prolonged time-to-surgery after neoadjuvant chemoradiotherapy for esophageal cancer: results from the multicenter, randomized, controlled NeoRes II trialAnders Holmén, Fahad Murad, Klara Nilsson, et al.
Ebiomedicine|February 1, 2023
An immune score reflecting pro- and anti-tumoural balance of tumour microenvironment has major prognostic impact and predicts immunotherapy response in solid cancersArtur Mezheyeuski, Max Backman, Johanna Mattsson, et al.
Pageof 4